Multi-centre experience on the use of perhexiline in chronic heart failure and refractory angina: Old drug, new hope

Thanh Trung Phan; Ganesh Nallur Shivu; Anirban Choudhury; Khalid Abozguia; Chris Davies; Ulasini Naidoo; Ibrar Ahmed; Zaheer Yousef; John Horowitz; Michael Frenneaux

doi:10.1093/eurjhf/hfp106

Multi-centre experience on the use of perhexiline in chronic heart failure and refractory angina: Old drug, new hope

Thanh Trung Phan, Ganesh Nallur Shivu, Anirban Choudhury, Khalid Abozguia, Chris Davies, Ulasini Naidoo, Ibrar Ahmed, Zaheer Yousef, John Horowitz, Michael Frenneaux

Research output: Contribution to journal › Article › peer-review

50 Citations (Scopus)

Abstract

The objective of this study is to report on our 5-year collective experience on the use of perhexiline in the UK, in patients with chronic heart failure (CHF) and/or refractory angina with respect to 'real-life' drug side effects and toxicity, therapeutic drug level monitoring, 5 year mortality outcomes and predictors of response to perhexiline therapy.

Original language	English
Pages (from-to)	881-886
Number of pages	6
Journal	European Journal of Heart Failure
Volume	11
Issue number	9
Early online date	20 Aug 2009
DOIs	https://doi.org/10.1093/eurjhf/hfp106
Publication status	Published - Sept 2009

Keywords

Chronic heart failure
Refractory angina
Perhexiline
Mortality and drug monitoring

Access to Document

10.1093/eurjhf/hfp106

Cite this

@article{93f8890f094b48678f6adc5b0ade855d,

title = "Multi-centre experience on the use of perhexiline in chronic heart failure and refractory angina: Old drug, new hope",

abstract = "The objective of this study is to report on our 5-year collective experience on the use of perhexiline in the UK, in patients with chronic heart failure (CHF) and/or refractory angina with respect to 'real-life' drug side effects and toxicity, therapeutic drug level monitoring, 5 year mortality outcomes and predictors of response to perhexiline therapy.",

keywords = "Chronic heart failure, Refractory angina, Perhexiline, Mortality and drug monitoring",

author = "Phan, {Thanh Trung} and Shivu, {Ganesh Nallur} and Anirban Choudhury and Khalid Abozguia and Chris Davies and Ulasini Naidoo and Ibrar Ahmed and Zaheer Yousef and John Horowitz and Michael Frenneaux",

year = "2009",

month = sep,

doi = "10.1093/eurjhf/hfp106",

language = "English",

volume = "11",

pages = "881--886",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "Wiley",

number = "9",

}

TY - JOUR

T1 - Multi-centre experience on the use of perhexiline in chronic heart failure and refractory angina: Old drug, new hope

AU - Phan, Thanh Trung

AU - Shivu, Ganesh Nallur

AU - Choudhury, Anirban

AU - Abozguia, Khalid

AU - Davies, Chris

AU - Naidoo, Ulasini

AU - Ahmed, Ibrar

AU - Yousef, Zaheer

AU - Horowitz, John

AU - Frenneaux, Michael

PY - 2009/9

Y1 - 2009/9

N2 - The objective of this study is to report on our 5-year collective experience on the use of perhexiline in the UK, in patients with chronic heart failure (CHF) and/or refractory angina with respect to 'real-life' drug side effects and toxicity, therapeutic drug level monitoring, 5 year mortality outcomes and predictors of response to perhexiline therapy.

AB - The objective of this study is to report on our 5-year collective experience on the use of perhexiline in the UK, in patients with chronic heart failure (CHF) and/or refractory angina with respect to 'real-life' drug side effects and toxicity, therapeutic drug level monitoring, 5 year mortality outcomes and predictors of response to perhexiline therapy.

KW - Chronic heart failure

KW - Refractory angina

KW - Perhexiline

KW - Mortality and drug monitoring

U2 - 10.1093/eurjhf/hfp106

DO - 10.1093/eurjhf/hfp106

M3 - Article

C2 - 19656806

SN - 1388-9842

VL - 11

SP - 881

EP - 886

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

IS - 9

ER -